BALTIMORE, MD, April 1, 2025 – Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations – showing biases like overconfidence of hot-hand (gambler’s) fallacy – yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).
You are swimming in an ocean of data and don’t even realize it. All around you are invisible amounts of data that would be staggering to try to comprehend. Thousands of smartphones and smart devices are talking to, sending and downloading vast amounts of data, video, audio, words, numbers, images, you name it. Everything from the latest movie on Netflix to someone’s radiology results from a cancer screening.
Mom-and-pop businesses are trying to adapt to the soaring cost of eggs. The owners of four egg-centric restaurants across the country show how they are coping with this threat to their livelihoods.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
A Food and Drug Administration advisory committee was meeting Thursday to discuss whether the agency should grant emergency use authorization for Pfizer Inc.'s coronavirus vaccine candidate. Later this month, members will meet on a vaccine from Moderna. In short, a vaccine is likely to be on its way to specific members of the public very soon.
The nation’s first COVID-19 vaccine stands on the verge of approval, yet the complex distribution of the product — and the risk along the way — is keeping some logistics and public health professionals up at night. The stakes could not be higher. This vaccine represents what one freight industry executive has termed “the biggest product launch in history.” Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.
Pfizer’s coronavirus vaccine is all but assured to become the first in the U.S. to win an emergency use authorization after an FDA panel voted to recommend the vaccine for widespread use. The company’s vaccine needs to be stored at ultra-low temperatures, which will require special freezers and shipping methods in order to ensure the vaccine remains potent.
More than 68 million infected with the novel coronavirus and more than 1.5 million dead. 2020 has been a year defined by global sickness and loss. In the face of this extraordinary threat, it’s easy to forget how much we have accomplished. Doctors, nurses and staff in hospitals around the world have learned how to better care for those sick with COVID-19. Researchers have uncovered secrets of a virus that, not so long ago, was wholly unknown.
The Pentagon expects to distribute 44,000 doses of covid-19 vaccine among military personnel and retirees against COVID as early as next week at 16 sites in what officials called a “controlled pilot.” Initial doses of the Pfizer vaccine will go to what officials described as a “limited, limited'' number of senior military officials and officers, including the Defense Secretary and Deputy Defense Secretary, the Chairmen and Vice Chairman of the Joints Chief and some others. But the bulk of the initial doses will go to the military healthcare workforce.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine